PatrickJGeraghtyMDFACS

Summary

• While maintaining a broad-based vascular surgical practice, Dr. Geraghty’s primary clinical and research focus has been the development and validation of new techniques to treat atherosclerotic and aneurysmal disease of the lower extremities. He has served as national and/or global principal investigator of the VIBRANT study of SFA intervention, FORMAT iliac stent trial, Lutonix Below The Knee study of paclitaxel-coated balloons for treatment of infrapopliteal disease, the Intact Vascular TOBA II Below The Knee trial of angioplasty salvage, and the Boston Scientific SAVAL Trial. In conjunction with his WUSM colleagues, Dr. Geraghty has worked to establish the first multidisciplinary limb salvage center in the St. Louis region.
  Dr. Geraghty has held several leadership roles in regional and national societies. He is a Past-President of the Midwestern Vascular Surgical Society. Nationally, he has served as chair of the Society for Vascular Surgery Technology Assessment Committee and member of the SVS Lower Extremity Practice Guidelines Writing Group and Global Vascular Guidelines Writing Group. He has provided advisory service to the FDA through the Peripheral Academic Research Consortium (PARC) and SVS Critical Limb Ischemia Work Group. His service to the SVS has been recognized through selection as one of the Society’s Distinguished Fellows.